Quadrant Capital Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-119
| Closed | -$6K | – | 2438 |
|
|
2020
Q3 | $6K | Sell |
119
-158
| -57% | -$6.54K | ﹤0.01% | 1509 |
|
|
2020
Q2 | $9K | Buy |
277
+11
| +4% | +$350 | ﹤0.01% | 1404 |
|
|
2020
Q1 | $7K | Buy |
266
+150
| +129% | +$4.18K | ﹤0.01% | 1559 |
|
|
2019
Q4 | $2K | Hold |
116
| – | – | ﹤0.01% | 2288 |
|
|
2019
Q3 | $1K | Hold |
116
| – | – | ﹤0.01% | 2259 |
|
|
2019
Q2 | $1K | Hold |
116
| – | – | ﹤0.01% | 2282 |
|
|
2019
Q1 | $1K | Hold |
116
| – | – | ﹤0.01% | 2231 |
|
|
2018
Q4 | $1K | Sell |
116
-74
| -39% | -$1.03K | ﹤0.01% | 2151 |
|
|
2018
Q3 | $3K | Hold |
190
| – | – | ﹤0.01% | 1787 |
|
|
2018
Q2 | $3K | Buy |
190
+74
| +64% | +$1.59K | ﹤0.01% | 1796 |
|
|
2018
Q1 | $1K | Hold |
116
| – | – | ﹤0.01% | 2099 |
|
|
2017
Q4 | $1K | Hold |
116
| – | – | ﹤0.01% | 2054 |
|
|
2017
Q3 | $1K | Hold |
116
| – | – | ﹤0.01% | 2071 |
|
|
2017
Q2 | $0 | Hold |
116
| – | – | ﹤0.01% | 2157 |
|
|
2017
Q1 | $1K | Hold |
116
| – | – | ﹤0.01% | 1965 |
|
|
2016
Q4 | $1K | Hold |
116
| – | – | ﹤0.01% | 1882 |
|
|
2016
Q3 | $1K | Hold |
116
| – | – | ﹤0.01% | 1877 |
|
|
2016
Q2 | $1K | Buy |
116
+107
| +1,189% | +$1.1K | ﹤0.01% | 1854 |
|
|
2016
Q1 | $0 | Sell |
9
-95
| -91% | -$1.02K | ﹤0.01% | 2075 |
|
|
2015
Q4 | $1K | Hold |
104
| – | – | ﹤0.01% | 1501 |
|
|
2015
Q3 | $1K | Hold |
104
| – | – | ﹤0.01% | 1142 |
|
|
2015
Q2 | $1K | Buy |
+104
| New | +$2.07K | ﹤0.01% | 1118 |
|
Quadrant Capital Group's MNTA Position: Q4 2020 in Review
Quadrant Capital Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 119 shares — an estimated $6K sold.
Quadrant Capital Group first reported a position in MNTA in Q2 2015 and held it in 22 quarters. The position peaked at $9K in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Quadrant Capital Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Quadrant Capital Group sold 119 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $6K.
- Quadrant Capital Group first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2015 and held it in 22 quarters.
- Quadrant Capital Group's Momenta Pharmaceuticals, Inc. position peaked at $9K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Quadrant Capital Group's 13F filing for Q4 2020, filed 16 Feb 2021.